Company Profile
 |
 |
 |
Chengdu VACURE Biotechnology Co., Ltd. was established in Chengdu, Sichuan in 2017. It was jointly founded by experts from the Thousand Talents Program of Sichuan Province, Chengdu Rongpiao Program experts, and a number of doctors and senior technical experts in the in vitro diagnostic industry.
VACURE Biotech currently has a team of 600+ people, including 15 doctors and 90+ masters, covering core functional sectors such as R&D, production, marketing, and sales, and focuses on creating affordable, accurate and intelligent on-site rapid detection solutions for acute and chronic diseases for the majority of small and medium-sized hospitals, clinical departments of tertiary hospitals, private hospitals and other medical institutions.
Based on three core technology of the patented flow capture microfluidic chip, time-resolved fluorescent Immunoassay TRFIA, nanomaterial inkjet freeze-dried,VACURE Biotech is committed to the research and development, production and sales of intelligent point-of-care testing (POCT) products in the field of in vitro diagnosis (IVD), providing innovative, convenient, accurate and best-cost POCT diagnostic products and Professional services.
R&D
Most of the R&D team members are more than 270. All the members are from global well-known research institutions or companies like Alere.
Workshop
The workshop covers an area of 18500 square meters.
The aseptic purification workshop meeting GMP standard:12000 square meters.
Chengdu Vacure Biotechnology Co., Ltd. has four subsidiary companies in China:
1. Hunan Kangxin Biotechnology: for Microfludic FIA production.
2. Sichuan Vacure Prelab Biotechnology: for Microfludic DISKFLU production.
3. Hunan Narui New Material Technology: for Antibody, Antigen, Micorspheres production.
4. Henan VACURE Biotechnology: for RT-PCR and POCT PCR production.
Products
3 world-leading product platforms: Microfluidics, Time-Resolved Fluorescence Immunoasay, POCT Molecular diagnosis.
There are nearly 100+ products under research and 120+ products have been certified.
Marketing network
From 2023, export to more than 60 countries such as Germany, Uk, Solovakia, Austria, Turkey, UAE, Ggypt, Kneya, Nigeira, India, Paksitan, Bangldesh, Philippines, Malaysia,etc.
VACURE has laid out four product lines of "microfluidic time-resolved immunofluorescence, disc-type microfluidic immunoassay, modular molecular diagnostic integrated microfluidics, and household electrochemical microfluidic rapid diagnostic platform", and has created a wealth of POCT products.
Team Presentation
 |
 |
 |
 |
 |
 |
Certificates
